Skip to content
sellNotable cluster of 4

11.2 Capital I Partners, LLC sold $45M of HNGE

owner at Hinge Health, Inc.. 1,396,340 shares at an average of $32.00, traded May 23, 2025, filed May 27, 2025.

Warning score
72
Value
$45M
1,396,340 shares
Holdings after
0
-100% from before
From 52-week low
+7%
low $37.56, close $40.16
From 52-week high
0%
high $40.16, as of May 23, 2025

Score components

  • Role
    10% owner
    +12
  • Trade size
    $44.7M at market
    +25
  • Share of holdings sold
    Sold 100% of holdings
    +20
  • Cluster
    4 insiders selling within 14 days
    +15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

HNGEOct 9, 2026 · close 102.90
Since filing May 27, 2025: +144.2%SPY +33.9% · excess +110.4%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000950170-25-077930, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
May 23, 2025CConversion
Class A Common Stockindirect: See footnotes
+1,396,340--1,396,340May 27, 2025
May 23, 2025SOpen-market sale
Class A Common Stockindirect: See footnotes
-1,396,340$32.00$45M0May 27, 2025
May 23, 2025JOther
Series S-1 Preferred Stockderivativeindirect: See footnotes
-1,455,604--0May 27, 2025
May 23, 2025JOther
Series A-1 Preferred Stockderivativeindirect: See footnotes
-230,923--0May 27, 2025
May 23, 2025JOther
Series A-2 Preferred Stockderivativeindirect: See footnotes
-1,932,367--0May 27, 2025
May 23, 2025JOther
Series C Preferred Stockderivativeindirect: See footnotes
-1,230,364--0May 27, 2025
May 23, 2025JOther
Series D Preferred Stockderivativeindirect: See footnotes
-251,606--0May 27, 2025
May 23, 2025JOther
Class B Common Stockderivativeindirect: See footnotes
+5,100,864--5,100,864May 27, 2025
May 23, 2025CConversion
Class B Common Stockderivativeindirect: See footnotes
-1,396,340--3,704,524May 27, 2025

Related signals

Other insiders at Hinge Health, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
41Moderate
HNGEsell10b5-1
Hinge Health, Inc.
Daniel Antonio Perez
CEO & Co-Founder
$411k
4,100 shares
-100%
40Moderate
HNGEsell 410b5-1
Hinge Health, Inc.
James Pursley
President
$3.1M
33,000 shares
-5%
55Moderate
HNGEsell 410b5-1
Hinge Health, Inc.
Gabriel M.I. Mecklenburg
director, other
$14M
150,000 shares
-100%
55Moderate
HNGEsell 410b5-1
Hinge Health, Inc.
Gabriel M.I. Mecklenburg
director, other
$22M
250,000 shares
-100%
47Moderate
HNGEsell 410b5-1
Hinge Health, Inc.
James Budge
Chief Financial Officer
$5.0M
55,561 shares
-14%
65Notable
HNGEsell 410b5-1
Hinge Health, Inc.
Daniel Antonio Perez
CEO & Co-Founder
$22M
250,000 shares
-172%
20Weak
HNGEsell10b5-1
Hinge Health, Inc.
James Budge
Chief Financial Officer
$508k
10,491 shares
-2%
35Weak
HNGEsell 210b5-1
Hinge Health, Inc.
James Budge
Chief Financial Officer
$2.1M
44,589 shares
-9%
16Weak
HNGEsell 210b5-1
Hinge Health, Inc.
James Budge
Chief Financial Officer
$35k
781 shares
-0%
50Moderate
HNGEsell 2
Hinge Health, Inc.
Bessemer Venture Partners X L.P.
owner
$29M
725,000 shares
-18%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

11.2 Capital I Partners, LLC sold $45M of HNGE | InsiderTell